Blog / glp 1

Semaglutide for MASH: What the ESSENCE Trial Shows and What to Track

What the ESSENCE trial found on semaglutide and fatty liver disease (MASH), what the FDA approved, and what to record for your provider.

By Peppy Team6 min read

More from the blog

Start with your next dose.

Download Peppy, the peptide tracker app for iPhone. Free to start, no account.